SavedAdd your journal

Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 4

Research of hepatitis a virus antibodies in children 0-18 aged in the province of Erzurum, Turkey

Ahmet YİLMAZ
Emine Fusun SAHİN
Pages
1198–1202
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pearson chi-square test was used to analyze the categorical data such as gender, age and seasonal differences in anti-HAV IgM and Anti-HAV IgG positivity rates and p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractAim: The aim of the study was to compare the anti-HAV IgG and Anti-HAV IgM seropositivity in children aged 0-18 in Erzurum with studies in our country and other countries, and also to evaluate the effect of seasons on hepatitis A infection.Material and Methods: The study was conducted on the serum samples of 5086 patients aged 0-18 years, who were considered to have Hepatitis A or who applied with different complaints as a result of the examination of family physicians in Erzurum between 2015 and 2018.
📊
Key Findings & Data:The results of these patients, obtained from Anti-HAV IgM and Anti-HAV IgG analysis by ELISA method in the Public Health Microbiology Laboratory, were evaluated retrospectively.
💡
Conclusion & Impact:Pearson chi-square test was used to analyze the categorical data such as gender, age and seasonal differences in anti-HAV IgM and Anti-HAV IgG positivity rates and p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

AbstractAim: The aim of the study was to compare the anti-HAV IgG and Anti-HAV IgM seropositivity in children aged 0-18 in Erzurum with studies in our country and other countries, and also to evaluate the effect of seasons on hepatitis A infection.Material and Methods: The study was conducted on the serum samples of 5086 patients aged 0-18 years, who were considered to have Hepatitis A or who applied with different complaints as a result of the examination of family physicians in Erzurum between 2015 and 2018. The results of these patients, obtained from Anti-HAV IgM and Anti-HAV IgG analysis by ELISA method in the Public Health Microbiology Laboratory, were evaluated retrospectively. Pearson chi-square test was used to analyze the categorical data such as gender, age and seasonal differences in anti-HAV IgM and Anti-HAV IgG positivity rates and p

🔖

Cite This Article

YİLMAZ, A., SAHİN, E. F. (2022). Research of hepatitis a virus antibodies in children 0-18 aged in the province of Erzurum, Turkey. Annals of Medical Research, Cilt: 27 - Sayı: 4, 1198–1202. https://ajindex.com/articles/446334

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Jorgensen JH, Pfaller MA. Manual of Clinical Microbiology. In: Anderson DA, Counihan NA, eds. Hepatitis A and E. 11th edition. Washington: ASM Press 2015;1584-98
  2. Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis 2015;28:488-96
  3. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010;2841:6653-7
  4. Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician 2006;73:2162-8
  5. Carrillo-Santisteve P, Tavoschi L, Severi E, et al. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. Lancet Infect Dis 2017;1710:306- 19
  6. Mehr AJ, Ardakani MJE, Hedayati M, et al. Agespecific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol 2004;19:275-8
  7. Sac RU, Bostancı I, Dallar Y, et al. Hepatitis A seroprevalence and demographics in Turkish children in Ankara. Pediatr Int 2009;51:5-8
  8. Tosun S, Ertan P, Kasirga E, et al. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediat int 2004;46:669- 72
  9. Kim HY, Eyheramonho MB, Pichavant M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest 2011;121:1111-8
  10. Lankarani KB, Mahmoodi M, Honarvar B, et al. Determinants of poor outcome in patients with hepatitis A infection: a four-year retrospective study in Shiraz, Southern Iran. Arch Virol 2014;159:1901-7
  11. Balamtekin N, Kalman S, Unay B, et al. Seroprevalence of hepatitis A in children living in the region of Kayseri. Gulhane Med J 2006;48:142-5
  12. Ozaras R, Arends JE. Viral Hepatitis. In: Turse EP, Rassow B, Tahan V, eds. Acute Hepatitis A. Chom: Springer Nature Switzerland AG 2019; 17-24
  13. World Heath Organization (WHO) Hepatitis A. https:// www.who.int/news-room/fact-sheets/detail/ hepatitis-a access date 19.09.2018 14. Gul HC, Avcı IY, Coskun O, et al. Anti-HAV seroprevalence in Turkish military personnel and its relation with demographic properties. Turk J Med Sci 2009;39:795-802
  14. Tekay F. Hepatitis a Frequency in Children of Between 0–14 Age Group who Had Consulted At Hakkari Province Hospital. Dicle Med J 2006;33:245-7
  15. Copur Cicek A, Ozkasap S, Dereci S, et al. Seroprevelance of HAV, HBV, HCV in Pediatric Patients in Rize City. Viral Hepat J 2012;18:102-6 17. Arvas G, Kaya B, Berktas M. The Se